Milind Deshpande

2012

In 2012, Milind Deshpande earned a total compensation of $1.5M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 41% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$201,272
Option Awards$922,084
Salary$376,100
Other$7,833
Total$1,507,289

Deshpande received $922.1K in option awards, accounting for 61% of the total pay in 2012.

Deshpande also received $201.3K in non-equity incentive plan, $376.1K in salary and $7.8K in other compensation.

Rankings

In 2012, Milind Deshpande's compensation ranked 4,553rd out of 11,487 executives tracked by ExecPay. In other words, Deshpande earned more than 60.4% of executives.

ClassificationRankingPercentile
All
4,553
out of 11,487
60th
Division
Manufacturing
1,580
out of 4,253
63rd
Major group
Chemicals And Allied Products
363
out of 1,198
70th
Industry group
Drugs
227
out of 920
75th
Industry
Pharmaceutical Preparations
176
out of 700
75th
Source: SEC filing on April 17, 2015.

Deshpande's colleagues

We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2012.

2012

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2012

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

2012

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2012

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

News

In-depth

You may also like